Latest news
Obsidian Therapeutics, Inc. Common Stock (OBX) interactive stock chart – Yahoo Finance - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 03:18:09 GMTObsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma - biospace.combiospace.com · Thu, 06 Aug 2026 03:07:48 GMTGalera Therapeutics (GRTX) CEO reports option and share disposition tied to merger - Stock TitanStock Titan · Wed, 05 Aug 2026 21:17:03 GMTGalera Therapeutics, Inc. (GRTX) details director option change - Stock TitanStock Titan · Wed, 05 Aug 2026 20:24:45 GMTGalera Therapeutics (NASDAQ: GRTX) details conversions tied to Obsidian merger - Stock TitanStock Titan · Wed, 05 Aug 2026 20:23:49 GMTGalera Therapeutics (NASDAQ: GRTX) director’s options converted in merger - Stock TitanStock Titan · Wed, 05 Aug 2026 20:23:02 GMTGalera Therapeutics (GRTX) CAO exits 10,000 stock options in merger - Stock TitanStock Titan · Wed, 05 Aug 2026 20:20:05 GMTGalera Therapeutics (GRTX) director details merger-driven stock and option moves - Stock TitanStock Titan · Wed, 05 Aug 2026 20:18:29 GMT